Pfizer says tilrekimig showed skin clearance in Phase 2 study
Pfizer said tilrekimig showed significant skin clearance in a Phase 2 atopic dermatitis study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.